SCHEMBL6537547

SCHEMBL6537547

COCc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)ccc(C)c2c1Cl

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGES O14684 7/20 0.42
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
TYK2 P29597 4/20 0.38
JAK2 O60674 3/20 0.38
JAK1 P23458 3/20 0.38
ABL1 P00519 2/20 0.37
SRC P12931 2/20 0.37
RAB9A P51151 1/20 0.37
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
TAS1R2 Q8TE23 1/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537929 0.85 PTGES (0.38) PTGESKMT2AMEN1POLBTYK2
SCHEMBL6537938 0.84 TYK2 (0.43) KMT2AMEN1POLBTYK2JAK2
SCHEMBL6537695 0.84 PTGES (0.44) PTGESKMT2AMEN1POLBTYK2
SCHEMBL6537712 0.83 CYP3A4 (0.43) PTGESKMT2AMEN1POLBTYK2
SCHEMBL6537304 0.81 PTGES (0.36) PTGESKMT2AMEN1POLBABL1
SCHEMBL6537737 0.80 PTGES (0.44) PTGESKMT2AMEN1POLBTYK2
SCHEMBL6537759 0.79 PTGES (0.44) PTGESKMT2AMEN1POLBTYK2
SCHEMBL6537573 0.78 TYK2 (0.43) KMT2AMEN1POLBTYK2JAK2
SCHEMBL6538012 0.77 PTGES (0.42) PTGESKMT2AMEN1POLBTYK2
SCHEMBL6537678 0.77 PTGES (0.42) PTGESKMT2AMEN1POLBTYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed